鹰架技术市场报告：2030 年趋势、预测与竞争分析

支架技术趋势与预测

全球支架技术市场的未来前景广阔，为生物技术和製药公司、合约实验室和学术机构市场提供了机会。预计2024年至2030年全球鹰架技术市场将以17.8%的复合年增长率成长。该市场的主要驱动力是对身体重组手术和组织工程的需求不断增长、生物材料使用的扩大以及支架技术的进步。

• 根据应用，Lucintel 预测，癌症细胞研究将成为预测期内最大的部分，因为癌症发生率的增加正在推动新型癌症预防和治疗策略的发展。
• 在最终用途类别中，学术机构将继续是最大的部分，因为支架技术广泛应用于牙周再生和软骨合成等组织工程领域。
• 从地区来看，由于癌症患者的快速增加、器官移植的增加以及生物技术和製药公司的扩张，北美在预测期内可能仍然是最大的地区。

支架技术市场的策略成长机会

支架技术市场在关键应用领域存在一些策略性成长机会。透过利用这些机会，我们可以促进创新并扩大支架技术在再生医学中的使用。

• 再生医学：支架技术在再生医学的应用具有巨大的成长潜力。支架透过提供结构支撑和促进细胞生长，在组织修復和器官再生中发挥重要作用。开发先进的再生医学支架可以解决未满足的医疗需求并推动市场扩张。
• 整形外科应用：支架技术为骨骼修復和软骨再生等整形外科应用提供了成长机会。具有增强机械性能和生物相容性的先进支架可以支持骨折和软骨损伤的癒合，并改善整形外科治疗中的患者预后。
• 人工植牙在牙科领域，支架技术正在推动牙科修復植入和组织工程解决方案的开发。专为牙科应用而设计的支架可以改善植入的完整性和功能，支持更好的口腔健康治疗效果，并扩大牙科支架技术的市场。
• 创伤治疗：支架技术在创伤治疗应用中具有巨大潜力。开发促进细胞迁移和组织再生的支架可以增强慢性伤口和烧烫伤的治疗。支架设计和材料的创新将改善创伤治疗效果并促进该领域的发展。
• 药物输送系统：支架也被考虑应用于药物输送系统。将治疗剂掺入支架中可提供受控和局部的药物释放，从而增强治疗效果。该应用为开发具有改进的靶向性和功效的先进药物输送解决方案提供了成长机会。

支架技术市场的策略性成长机会包括再生医学、整形外科、人工植牙、创伤治疗和药物传输系统等应用。这些机会提供了创新和扩展的潜力，促进了先进支架技术在各个医疗领域的开发和采用。

支架技术市场驱动因素与挑战

支架技术市场受到材料科学进步、再生医学需求增加、研究投资增加、监管动态和市场竞争的推动和挑战。了解这些因素对于驾驭市场并克服支架技术成长和创新的障碍至关重要。

推动鹰架技术市场的因素是：

• 技术进步：3D 列印、奈米技术和智慧材料正在彻底改变支架技术。这些创新改善了支架功能、客製化特性和整体性能，增强了组织再生并开启了新的可能性。
• 对再生医学的需求不断增加：对再生医学和组织工程的日益关注正在推动对更复杂的支架解决方案的需求。支架在支持组织修復和器官再生方面发挥重要作用，有助于治疗复杂的病理和损伤。
• 增加研发投入：创新研发的投资正在推动鹰架开发产业的变革。私人企业、政府机构和研究机构加大对新材料、新技术和应用开发的支持正在推动市场扩张。
• 意识和医疗保健需求的提高：人们对支架益处的认识不断提高，再生疗法不断增加，正在推动市场成长。随着医疗保健需求的不断发展，需要能够灵活应对各种医疗状况的先进支架解决方案。
• 对创新的监管支援：监管机构在创造进步的法规环境以促进支架相关新技术的引入方面发挥重要作用。这样的环境创造了快速进入市场的途径，并支援先进鹰架解决方案的开发。

脚手架技术市场的挑战包括：

• 先进技术的高成本：与先进支架技术（例如专用材​​料和製造流程）相关的高成本使许多人难以获得并限制了这些解决方案的采用。对于价格敏感的市场，先进的鹰架可能难以负担，从而限制了它们的使用。
• 支架设计和製造的复杂性：支架设计和製造需要组织工程和材料科学专业知识。这些过程通常很复杂，这使得确保每个鹰架在製造过程中耐用、可靠且功能齐全成为品质挑战。这些问题降低了基于支架的治疗的效率。

技术进步、再生医学需求的增加、研发活动的投资、医疗需求的增加以及监管支持是推动支架技术市场的因素。然而，高成本、设计复杂性、监管障碍和结果不一致等挑战仍然存在，需要专注于促进该领域的成长和创新。

目录

第一章执行摘要

第二章全球支架技术市场：市场动态

• 简介、背景、分类
• 供应链
• 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

• 宏观经济趋势（2018-2023）与预测（2024-2030）
• 全球支架技术市场趋势（2018-2023）与预测（2024-2030）
• 全球支架技术市场：副产品
  • 天然支架
  • 合成支架
• 全球脚手架技术市场：按类型
  • 大孔支架
  • 微孔支架
  • 奈米多孔支架
  • 固体的鹰架
• 全球鹰架技术市场：依应用分类
  • 药物发现
  • 再生医学
  • 癌细胞研究
  • 干细胞研究
• 全球脚手架技术市场：依最终用途分类
  • 生物技术和製药公司
  • 合约调查机构
  • 学术机构

第四章 2018-2030年区域市场趋势及预测分析

• 全球鹰架技术市场：按地区
• 北美脚手架技术市场
• 欧洲脚手架技术市场
• 亚太地区脚手架技术市场
• 其他地区鹰架技术市场

第五章 竞争分析

• 产品系列分析
• 营运整合
• 波特五力分析

第六章 成长机会与策略分析

• 成长机会分析
  • 全球支架技术市场按产品分類的成长机会
  • 按类型分類的全球支架技术市场成长机会
  • 全球支架技术市场应用的成长机会
  • 按最终用途分類的全球支架技术市场成长机会
  • 全球支架技术市场区域成长机会
• 全球鹰架技术市场的新兴趋势
• 战略分析
  • 新产品开发
  • 扩大全球支架技术市场的产能
  • 全球脚手架技术市场的合併、收购和合资企业
  • 认证和许可

第七章主要企业概况

• Synthecon
• Bico
• Lonza
• Thermo Fisher Scientific
• Avantor
• ReproCELL
• 3D Biotek
• Corning
• Becton, Dickinson, &Company
• InSphero

Scaffold Technology Trends and Forecast

The future of the global scaffold technology market looks promising with opportunities in the biotechnology & pharmaceutical company, contract research laboratory, and academic institute markets. The global scaffold technology market is expected to grow with a CAGR of 17.8% from 2024 to 2030. The major drivers for this market are increasing demand for procedures in body reconstruction and tissue engineering, growing utilization of biomaterials, as well as, advancements in scaffold technology.

• Lucintel forecasts that, within the application category, cancer cell research will remain the largest segment over the forecast period due to an increase in cancer incidence that has prompted the creation of novel cancer prevention and treatment strategies.
• Within the end-use category, academic institutes will remain the largest segment because the scaffold technology is widely employed in tissue engineering domains like periodontal regeneration and cartilage synthesis.
• In terms of regions, North America will remain the largest region over the forecast period due to a surge in cancer cases, growth in organ transplantations, and expansion of biotechnology and pharmaceutical firms.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Scaffold Technology Market

The scaffold technology market is experiencing several emerging trends that reflect advancements in materials science, fabrication techniques, and clinical applications. These trends are reshaping the landscape of tissue engineering and regenerative medicine.

• 3D Bioprinting: The use of 3D bioprinting technology is revolutionizing scaffold production by enabling precise and customizable scaffold designs. With this trend, complex, patient-specific structures can be created to improve tissue regeneration or repair. Additionally, bioprinting allows the incorporation of multiple cell types and growth factors within scaffolds, enhancing their functionality.
• Smart Scaffolds: Smart scaffolds that respond to environmental stimuli, such as changes in pH or temperature, are gaining traction. These materials can adapt to biological conditions, facilitating controlled drug release or specific cellular responses. This makes scaffold-based therapy more effective and further supports dynamic tissue regeneration.
• Nanotechnology Integration: Incorporating nanotechnology into scaffold design is improving material properties and performance. Nanomaterials enhance strength, porosity, biocompatibility, and cell integration, which contribute to better tissue formation within the scaffolds. They also enable the development of special functions, such as antimicrobial properties and enhanced cell interactions, for use in specific types of scaffolds.
• Regenerative Medicine Applications: Scaffold technology is increasingly being applied in regenerative medicine, such as tissue engineering and organ regeneration. The application of advanced biomaterials and scaffold designs has led to the formation of functional tissues and organs, which can be used to treat complex diseases or injuries.
• Personalized Medicine: The shift toward personalized medicine has resulted in a growing demand for customized scaffolds made specifically for individuals. Innovations in 3D scanning and bioprinting technologies have led to the development of tailor-made scaffolds that match a patient's bodily structure, thereby improving treatment outcomes and patient satisfaction.

Emerging trends in the scaffold technology market, including 3D bioprinting, smart materials, biodegradable scaffolds, hybrid scaffolds, and personalized medicine, are advancing the field of tissue engineering. These trends are driving innovation, improving scaffold functionality, and expanding applications in regenerative medicine, ultimately enhancing treatment outcomes and patient care.

Recent Developments in the Scaffold Technology Market

Recent developments in the scaffold technology market highlight significant advancements in materials, fabrication techniques, and clinical applications. These developments are advancing the field of tissue engineering and regenerative medicine.

• Advancements in 3D Bioprinting: The development of three-dimensional (3D) bioprinting has revolutionized scaffold production, enabling highly tailored designs of intricate structures. This means biological architectures, including pore size and spatial cell distribution, can now be precisely controlled, facilitating better tissue integration and regeneration. Bioprinting allows individual patient needs to be met, resulting in personalized scaffolds.
• Development of Smart Scaffolds: Scaffold technology has become smarter by introducing responsive properties that help scaffolds adapt to physiological changes. These smart scaffolds are constructed using materials that can change their characteristics under environmental conditions, such as pH or temperature variations. This innovation allows dynamic treatment approaches, such as controlled drug delivery or live monitoring of tissue development.
• Integration of Nanotechnology: Nanotechnology enhances various material features at the nanoscale, improving scaffold design. Nanomaterials incorporated into the scaffold improve strength, biocompatibility, and cellular interactions. Furthermore, scaffolds can now be developed with additional functionalities, such as antimicrobial properties, which contribute significantly to overall treatment outcomes.
• Focus on Biodegradable Materials: Recent developments have focused on using biodegradable materials in scaffold technology. Biodegradable scaffolds eliminate the need for secondary surgeries, thus reducing long-term complications and supporting natural tissue growth. Advances in biodegradable polymers and composites have increased the efficacy and safety of scaffold-based treatments.
• Increased Research in Regenerative Medicine: More studies are being conducted on integrating scaffold technology into regenerative medicine applications. Significant innovations include combining scaffolds with stem cells and growth factors, leading to tissue repair or regeneration. This has opened up prospects for functional tissue or organ replacements to address complex medical conditions or injuries.

Recent developments in the scaffold technology market, including advancements in 3D printing, biomaterials, regulatory frameworks, manufacturing techniques, and collaborative research, are driving innovation and improving the field of tissue engineering. These developments enhance scaffold functionality, support regulatory compliance, and expand the potential applications of scaffold technologies.

Strategic Growth Opportunities for Scaffold Technology Market

The scaffold technology market presents several strategic growth opportunities across key applications. Capitalizing on these opportunities can drive innovation and expand the use of scaffold technologies in regenerative medicine.

• Regenerative Medicine: The application of scaffold technology in regenerative medicine offers significant growth potential. Scaffolds play a crucial role in tissue repair and organ regeneration by providing structural support and promoting cell growth. Developing advanced scaffolds for regenerative medicine can address unmet medical needs and drive market expansion.
• Orthopedic Applications: Scaffold technology presents growth opportunities in orthopedic applications, such as bone repair and cartilage regeneration. Advanced scaffolds with enhanced mechanical properties and biocompatibility can support the healing of bone fractures and cartilage injuries, improving patient outcomes in orthopedic treatments.
• Dental Implants: In the dental field, scaffold technology is advancing the development of implants and tissue engineering solutions for dental repairs. Scaffolds designed for dental applications can improve the integration and functionality of implants, supporting better outcomes in oral health treatments and expanding the market for dental scaffold technologies.
• Wound Healing: Scaffold technology has significant potential in wound healing applications. Developing scaffolds that promote cell migration and tissue regeneration can enhance the treatment of chronic wounds and burns. Innovations in scaffold design and materials can improve wound healing outcomes and drive growth in this segment.
• Drug Delivery Systems: Scaffolds are also being explored for use in drug delivery systems. Incorporating therapeutic agents into scaffolds allows for controlled and localized drug release, enhancing treatment efficacy. This application offers growth opportunities in developing advanced drug delivery solutions with improved targeting and effectiveness.

Strategic growth opportunities in the scaffold technology market include applications in regenerative medicine, orthopedics, dental implants, wound healing, and drug delivery systems. These opportunities offer potential for innovation and expansion, driving the development and adoption of advanced scaffold technologies in various medical fields.

Scaffold Technology Market Driver and Challenges

The scaffold technology market is driven and challenged by advancements in material science, increasing demand for regenerative medicine, rising research investments, regulatory dynamics, and market competition. To navigate the market and overcome hurdles to growth and innovation in scaffold technology, it is important to understand these factors.

The factors responsible for driving the scaffold technology market include:

• Technological Advancements: 3D printing, nanotechnology, and smart materials are revolutionizing scaffold technology. These innovations have improved scaffold functionality, customization properties, and overall performance, which has enhanced tissue regeneration and opened up new possibilities.
• Increasing Demand for Regenerative Medicine: The increasing emphasis on regenerative medicine and tissue engineering has fueled the demand for more sophisticated scaffold solutions. Scaffolds play an essential role in supporting tissue repair and organ regeneration, which help in treating complex medical conditions and injuries.
• Rising Investment in Research and Development: Investment in innovative research is promoting changes in the scaffold development industry. There is increased support from private companies, governmental organizations, and research institutions toward developing new materials, technologies, and applications, thereby facilitating market expansion.
• Growing Awareness and Healthcare Needs: Increasing awareness of the benefits of scaffolding, along with rising incidences of regenerative therapies, are propelling market growth. Advanced scaffold solutions are needed to flexibly address different medical conditions, as healthcare needs continue to evolve.
• Regulatory Support for Innovation: Regulatory bodies play a crucial role in creating advanced regulatory environments that encourage the introduction of new technologies related to scaffolds. These environments help create fast pathways to market entry, thus supporting the development of advanced scaffold solutions.

Challenges in the scaffold technology market include:

• High Costs of Advanced Technologies: High costs associated with advanced scaffold technologies, including specialized materials and manufacturing processes, make it difficult for many to access these solutions, limiting their adoption rates. Price-sensitive markets may find advanced scaffolds unaffordable, thus limiting their availability.
• Complexity of Scaffold Design and Production: Designing and producing scaffolds requires expertise in tissue engineering and materials science. These processes are often complex, and ensuring that each scaffold is durable, reliable, and functional during manufacturing poses quality challenges. These issues can reduce the efficiency of scaffold-based treatments.

Advances in technology, increased demand for regenerative medicine, investment in R&D activities, growing healthcare needs, and regulatory support are some of the factors driving the scaffold technology market. However, challenges such as high costs, design complexity, regulatory hurdles, and inconsistent outcomes remain, requiring attention to drive growth and innovation in the sector.

List of Scaffold Technology Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies scaffold technology companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the scaffold technology companies profiled in this report include-

• Synthecon
• Bico
• Lonza
• Thermo Fisher Scientific
• Avantor
• ReproCELL
• 3D Biotek
• Corning
• Becton, Dickinson, &Company
• InSphero

Scaffold Technology by Segment

The study includes a forecast for the global scaffold technology by product type, type, application, end use, and region.

Scaffold Technology Market by Product Type [Analysis by Value from 2018 to 2030]:

• Natural Scaffold
• Synthetic Scaffold

Scaffold Technology Market by Type [Analysis by Value from 2018 to 2030]:

• Macro-Porous Scaffolds
• Micro-Porous Scaffolds
• Nano-Porous Scaffolds
• Solid Scaffolds

Scaffold Technology Market by Application [Analysis by Value from 2018 to 2030]:

• Drug Discovery
• Regenerative Medicine
• Cancer Cell Research
• Stem Cell Research

Scaffold Technology Market by End Use [Analysis by Value from 2018 to 2030]:

• Biotechnology & Pharmaceutical Companies
• Contract Research Laboratories
• Academic Institutes

Scaffold Technology Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Scaffold Technology Market

Scaffold technology is crucial for tissue engineering and regenerative medicine, offering innovative solutions for repairing or replacing damaged tissues and organs. Recent advancements reflect the growing emphasis on improving biomaterials, fabrication techniques, and clinical applications across different regions. Below is an overview of recent developments in the scaffold technology market in the United States, China, Germany, and India.

• United States: Recent developments in the U.S. scaffold technology market include advancements in 3D bioprinting and personalized scaffolds. Research is focused on 3D printing patient-specific scaffolds to enhance tissue regeneration. Additionally, there is ongoing work to incorporate smart biomaterials into scaffolds, enabling them to sense biological signals and improving their functionality in regenerative medicine.
• China: In China, the scaffold technology market is experiencing growth driven by increased investment in regenerative medicine and tissue engineering. Innovations include the development of composite scaffolds made from polymers combined with natural substances, which improve scaffold performance and support tissue regeneration. There is also a growing emphasis on scaling up production capabilities to enable broader market access.
• Germany: Germany's progress in scaffold technology is driven by cutting-edge research on biodegradable materials and advanced manufacturing techniques. These innovations focus on creating scaffolds with enhanced mechanical properties and controlled degradation rates. Additionally, Germany is exploring the combination of scaffold treatments with other therapeutic solutions, such as gene therapy or cellular therapy, to achieve better outcomes.
• India: In India, the scaffold technology market is evolving with a focus on affordable and scalable solutions. Recent advances include the development of cost-effective yet biocompatible materials, along with the establishment of research collaborations aimed at boosting scaffold performance. Scaffold technology is also being explored to address large-scale tissue engineering challenges in clinical settings.

Features of the Global Scaffold Technology Market

Market Size Estimates: Scaffold technology market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Scaffold technology market size by product type, type, application, end use, and region in terms of value ($B).

Regional Analysis: Scaffold technology market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product type, type, application, end use, and regions for the scaffold technology market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the scaffold technology market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the scaffold technology market by product type (natural scaffold and synthetic scaffold), type (macro-porous scaffolds, micro-porous scaffolds, nano-porous scaffolds, and solid scaffolds), application (drug discovery, regenerative medicine, cancer cell research, and stem cell research), end use (biotechnology & pharmaceutical companies, contract research laboratories, and academic institutes), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Scaffold Technology Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Scaffold Technology Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Scaffold Technology Market by Product Type
  • 3.3.1: Natural Scaffold
  • 3.3.2: Synthetic Scaffold
• 3.4: Global Scaffold Technology Market by Type
  • 3.4.1: Macro-Porous Scaffolds
  • 3.4.2: Micro-Porous Scaffolds
  • 3.4.3: Nano-Porous Scaffolds
  • 3.4.4: Solid Scaffolds
• 3.5: Global Scaffold Technology Market by Application
  • 3.5.1: Drug Discovery
  • 3.5.2: Regenerative Medicine
  • 3.5.3: Cancer Cell Research
  • 3.5.4: Stem Cell Research
• 3.6: Global Scaffold Technology Market by End Use
  • 3.6.1: Biotechnology & Pharmaceutical Companies
  • 3.6.2: Contract Research Laboratories
  • 3.6.3: Academic Institutes

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Scaffold Technology Market by Region
• 4.2: North American Scaffold Technology Market
  • 4.2.1: North American Market by Application: Drug Discovery, Regenerative Medicine, Cancer Cell Research, and Stem Cell Research
  • 4.2.2: North American Market by End Use: Biotechnology & Pharmaceutical Companies, Contract Research Laboratories, and Academic Institutes
• 4.3: European Scaffold Technology Market
  • 4.3.1: European Market by Application: Drug Discovery, Regenerative Medicine, Cancer Cell Research, and Stem Cell Research
  • 4.3.2: European Market by End Use: Biotechnology & Pharmaceutical Companies, Contract Research Laboratories, and Academic Institutes
• 4.4: APAC Scaffold Technology Market
  • 4.4.1: APAC Market by Application: Drug Discovery, Regenerative Medicine, Cancer Cell Research, and Stem Cell Research
  • 4.4.2: APAC Market by End Use: Biotechnology & Pharmaceutical Companies, Contract Research Laboratories, and Academic Institutes
• 4.5: ROW Scaffold Technology Market
  • 4.5.1: ROW Market by Application: Drug Discovery, Regenerative Medicine, Cancer Cell Research, and Stem Cell Research
  • 4.5.2: ROW Market by End Use: Biotechnology & Pharmaceutical Companies, Contract Research Laboratories, and Academic Institutes

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Scaffold Technology Market by Product Type
  • 6.1.2: Growth Opportunities for the Global Scaffold Technology Market by Type
  • 6.1.3: Growth Opportunities for the Global Scaffold Technology Market by Application
  • 6.1.4: Growth Opportunities for the Global Scaffold Technology Market by End Use
  • 6.1.5: Growth Opportunities for the Global Scaffold Technology Market by Region
• 6.2: Emerging Trends in the Global Scaffold Technology Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Scaffold Technology Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Scaffold Technology Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Synthecon
• 7.2: Bico
• 7.3: Lonza
• 7.4: Thermo Fisher Scientific
• 7.5: Avantor
• 7.6: ReproCELL
• 7.7: 3D Biotek
• 7.8: Corning
• 7.9: Becton, Dickinson, &Company
• 7.10: InSphero